In summary, various crosstalk mechanisms between BCR, CD40, and TLR signaling have been described in CLL based on receptor expression levels, the activation of downstream mediators as well as the use of targeted inhibitors (Figure 3). This evidence concerns the gene BCR and B-cell chronic lymphocytic leukemia.